Search

everythinglearnresearchcommunity

for

Search:↓

LPR1 regulates root growth under low phosphate stress independently of SIZ1 in Arabidopsis thaliana.

Low-level light therapy is used in cosmetics and dermatology to repair skin, reduce inflammation, and treat various skin conditions.

Most transgender patients getting laser hair removal before gender-affirming surgery are already on hormone therapy, which might affect the hair removal process.

RCS-01 therapy is safe and may improve skin structure by affecting gene expression.

Low-level light therapy safely improves hair coverage, thickness, and count in androgenetic alopecia patients.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

A boy developed a rare skin condition after recovering from a severe skin reaction, and it improved with lotion treatment.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

rTMS may help treat trichotillomania in some patients.

A high neutrophil-to-lymphocyte ratio may predict poor response to hair loss treatment.

Red light therapy temporarily increased blood flow in the eye but didn't change other eye structures.

Low-level laser therapy is a safe and effective long-term treatment for hair loss, improving hair density and thickness.

Low-level laser therapy effectively prevents and treats oral mucositis.

Most patients with alopecia areata see significant hair regrowth within 93 days of starting ritlecitinib treatment.

Long-lived proteins may predict age-related diseases.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

Long-pulsed ruby laser effectively reduces hair in male-to-female transsexuals.

Trans-esophageal echocardiography is crucial for accurately diagnosing heart issues in lupus patients.

Low-level laser therapy can boost cell activity and energy production.

Low-Level Laser Therapy may help reduce chronic pelvic pain in women.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

FERONIA and LRX proteins help control cell growth in plants by regulating vacuole expansion.

Researchers created a mouse with the same mutation as humans with trichothiodystrophy, showing similar symptoms and confirming the condition is due to defects in DNA repair and gene activity.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Low-Level Light Therapy significantly reduced inflammation and promoted hair regrowth in patients with Lichen planopilaris.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.